Heron Therapeutics (HRTX) Interest & Investment Income (2010 - 2017)
Heron Therapeutics (HRTX) reported Interest & Investment Income of $3.4 million for Q4 2017, up 123.07% on a YoY basis from $1.5 million in Q4 2016, and up 711.41% quarter-over-quarter from -$552000.0 in Q3 2017.
Heron Therapeutics (HRTX) Interest & Investment Income (2010 - 2017) Analysis & Trends
Heron Therapeutics has reported Interest & Investment Income for 6 years, with the latest figure at $3.4 million in Q4 2017.
- For the quarter ending Q4 2017, Interest & Investment Income rose 123.07% year-over-year to $3.4 million; the trailing twelve-month figure through Dec 2017 stood at $3.6 million (up 881.42% YoY), and the FY2025 full-year result was $1.9 million, down 45.13% from the prior year.
- Interest & Investment Income for Q4 2017 stood at $3.4 million, up from -$552000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $3.4 million in Q4 2017, with the low at -$775000.0 in Q3 2016.
- Historically, Interest & Investment Income has averaged $183100.0 across 3 years, with a median of -$206500.0 in 2013.
- The largest YoY upside for Interest & Investment Income was 123.07% in 2017 against a maximum downside of 365.0% in 2017.
- Heron Therapeutics' Interest & Investment Income stood at -$212000.0 in 2013, then soared by 813.68% to $1.5 million in 2016, then surged by 123.07% to $3.4 million in 2017.
- The last three Interest & Investment Income figures came in at $3.4 million (Q4 2017), -$552000.0 (Q3 2017), and -$744000.0 (Q2 2017), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 597,319.59 |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -14.79 Mn |
| 10 | Heron Therapeutics | 77.43 Mn | 47.47 Mn | 24.07 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 3.38 Mn |
| Sep 30, 2017 | -552,000.00 |
| Jun 30, 2017 | -744,000.00 |
| Dec 31, 2016 | 1.51 Mn |
| Sep 30, 2016 | -775,000.00 |
| Jun 30, 2016 | -160,000.00 |
| Dec 31, 2013 | -212,000.00 |
| Sep 30, 2013 | -209,000.00 |
| Jun 30, 2013 | -204,000.00 |
| Mar 31, 2013 | -201,000.00 |
| Dec 31, 2012 | -197,000.00 |
| Sep 30, 2012 | -195,000.00 |
| Jun 30, 2012 | -146,000.00 |
| Mar 31, 2012 | -61,000.00 |
| Dec 31, 2011 | -47,000.00 |
| Sep 30, 2011 | -62,000.00 |
| Jun 30, 2011 | -263,000.00 |
| Mar 31, 2011 | -1,000.00 |
| Sep 30, 2010 | -1,000.00 |